Like me, you may be drawn to new technologies surrounding diabetes diagnosis and management. Consequently, this Massachusetts General Hospital study involving the early recognition of Type 2 Diabetes on the basis of biomarkers is fascinating.
Basically, the study authors performed ”metabolomics” on data from 2,422 individuals, which means, they profiled their metabolic status from blood samples and did so over a 12 year period.
Ten percent of the studied population developed diabetes.
The investigation found that specific amino acids were correlated with the future onset of diabetes. These included isoleucine, leucine, valine, tyrosine and phenylalanine. The combined level of three of these were able to identify individual with a five-fold risk of diabetes.
The results underscore that diabetes is not simply a disease about high blood sugar but involves a number of factors which includes amino acid metabolism.